Phenotypic alterations and cytokine production in THP-1 cells in response to allergens.

In the induction phase of allergic contact hypersensitivity, dendritic cells (DCs), including Langerhans cells (LCs) present in epidermis, can trigger an efficient T cell response once they have matured in response to an allergen. Upon maturation, DCs have been shown to induce expression of several surface molecules and the up-regulation of cytokine production. We have previously shown that THP-1 cells, human acute monocytic leukemia cell line, can discriminate between allergens and irritants by measuring expression of surface markers, CD86 and CD54, following chemical exposure. At the same time, we have also reported that augmented expression of HLA and CD80, and production of IL-1beta were up-regulated in THP-1 cells when treated with an allergen, 2,4-dinitrochlorobenzene (DNCB). In the present study, we first evaluated whether THP-1 cells induced the phenotypic changes and the production of cytokines, which are observed in the process of DC maturation, when treated with two known allergens, DNCB and nickel sulfate (NiSO(4)), and one irritant (sodium lauryl sulfate (SLS)). Exposure to DNCB and NiSO(4) induced significant augmentation of CD40 and CD83 expression as well as CD86 and CD54. Also, TNF-alpha and IL-8 secretion were markedly induced by DNCB and NiSO(4) in a dose-dependent manner. In addition, DNCB and NiSO(4) augmented CD1a expression and production of IL-6, respectively. On the contrary, SLS did not change any of these markers. We then evaluated a series of chemicals, including six known allergens (e.g., hydroquinone (HQ)) and two non-allergens (e.g., methyl paraben (MP)), in order to investigate the potential increase of CD86, CD54, CD40, and CD83 expression on THP-1 cells, and production of TNF-alpha and IL-8. Indeed, all tested allergens, except eugenol (EU), caused significant increased changes in at least four of the analyzed six markers, while non-allergens did not induce any changes. EU significantly augmented CD86, CD54 and CD40 expression. These results revealed that the wide variety of responses to allergens in THP-1 cells may emulate allergen-induced maturation processes of DCs. It is suggested that THP-1 cells, which could develop several DC-like properties, are suitable for identifying sensitizing potential of chemicals.

[1]  J. Salamero,et al.  CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells. , 2001, The Journal of investigative dermatology.

[2]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[3]  Liangji Zhou,et al.  Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. , 1995, Journal of immunology.

[4]  D. Basketter,et al.  The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  H. Tagami,et al.  Simple chemicals can induce maturation and apoptosis of dendritic cells , 1999, Immunology.

[6]  S. Aiba,et al.  Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co‐stimulatory molecules , 1997, European journal of immunology.

[7]  J. Bos,et al.  Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation. , 1994, Journal of immunology.

[8]  S. Hopkins,et al.  Deficiency of IL‐2 or IL‐6 reduces lymphocyte proliferation, but only IL‐6 deficiency decreases the contact hypersensitivity response , 2000, European journal of immunology.

[9]  H. Sakaguchi,et al.  Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  D. Schmitt,et al.  Fragrance and Contact Allergens in vitro Modulate the HLA–DR and E–Cadherin Expression on Human Epidermal Langerhans Cells , 1999, International Archives of Allergy and Immunology.

[11]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  I. Kimber,et al.  Development of a murine local lymph node assay for the determination of sensitizing potential , 1986 .

[13]  S. Aiba,et al.  Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  P. Amerio,et al.  Role of cytokines in epidermal Langerhans cell migration , 1999, Journal of leukocyte biology.

[16]  J. Banchereau,et al.  Functional expression of CD40 antigen on human epidermal Langerhans cells. , 1995, Journal of immunology.

[17]  Z. Berneman,et al.  Cytokine transcript profiling in CD34+-progenitor derived dendritic cells exposed to contact allergens and irritants. , 2005, Toxicology letters.

[18]  G Frank Gerberick,et al.  Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. , 2005, Toxicology and applied pharmacology.

[19]  A. Cordier,et al.  Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  S. Nakagawa,et al.  Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. , 1996, The Journal of investigative dermatology.

[21]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[22]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Nakagawa,et al.  p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. , 2003, The Journal of investigative dermatology.

[24]  M. Flint,et al.  Production and in situ localization of cutaneous tumour necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) following skin sensitization. , 1998, Cytokine.

[25]  S. Nakagawa,et al.  Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. , 2005, The Journal of investigative dermatology.

[26]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[27]  Z. Berneman,et al.  Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants. , 2005, Toxicology letters.

[28]  A. De Smedt,et al.  Modulation of phenotype, cytokine production and stimulatory function of CD34+-derived DC by NiCl(2) and SDS. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  Z. Berneman,et al.  Phenotypic alterations and IL-1β production in CD34+ progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis , 2002, Archives of Dermatological Research.

[30]  J. Banchereau,et al.  Functions of CD40 on B cells, dendritic cells and other cells. , 1997, Current opinion in immunology.

[31]  I. Kimber,et al.  Constitutive and inducible expression of interleukin‐6 by Langerhans cells and lymph node dendritic cells , 1996, Immunology.

[32]  D. Schmitt,et al.  Moderate skin sensitizers can induce phenotypic changes on in vitro generated dendritic cells. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[33]  C. Ryan,et al.  Approaches for the development of cell-based in vitro methods for contact sensitization. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[34]  Koichiro Nakamura,et al.  Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells1. , 1999, The Journal of investigative dermatology.

[35]  A. Kligman,et al.  The Identification of Contact Allergens by Animal Assay. the Guinea Pig Maximization Test , 1969 .

[36]  D. Hart,et al.  Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.

[37]  H. Tuschl,et al.  The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.

[38]  E. Clark,et al.  Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. , 1996, Journal of immunology.